Well-planned regulatory strategies–including Chemistry/Manufacturing Controls (CMC), pharmacological, and toxicological studies–are critical for drug development programs. PharmaNet Consulting professionals include former senior-level officials with both the FDA Center for Drug Evaluation and Research (CDER) and international agencies. These professionals understand the unique issues related to drugs of small molecules, and can assist you with regulatory strategy, CMC, clinical trial design issues, and other technical considerations to gain marketing approval for your products.
PharmaNet professionals available for consultation on this topic include:
Director, Drug Development, Scientific and Regulatory Affairs, Anapharm
Project Manager, Drug Development, Scientific and Regulatory Affairs, Anapharm
Executive Director, PharmaNet Consulting
504 Carnegie Center, Princeton, NJ 08540